Literature DB >> 17390766

Urticarial vasculitis.

Suyoung Chang1, Warner Carr.   

Abstract

A case of urticarial vasculitis (UV) is presented. The pathogenesis, clinical characteristics, diagnosis, and management of this disease are reviewed, followed by clinical pearls and pitfalls for the practicing allergist (Venzor J, et al., Urticarial vasculitis, Clin Rev Allergy Immunol 23:201-216, 2002). The lesions in UV typically lasts > 24 hours in a fixed location, resolves with residual hyperpigmentation, and may or may not be pruritic. In contrast, standard urticaria lesions persist < 24 hours, leave no trace, and is always pruritic (Black AK, Urticarial vasculitis, Clin Dermatol 17:565-569, 1999). Since urticarial vasculitis is characterized by a variety of cutaneous, systemic, and serological features, different names of this disorder exist in the literature (Wisnieski JJ, Urticarial vasculitis, Curr Opin Rheumatol 12:24-31, 2000). A biopsy of an active lesion remains the gold standard for the diagnosis of urticarial vasculitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390766     DOI: 10.2500/aap.2007.28.2972

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  7 in total

1.  ASIA - a dangerous beauty?

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva
Journal:  Wien Med Wochenschr       Date:  2016-11-10

2.  Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature.

Authors:  Misbah Nasheela Ghazanfar; Simon Francis Thomsen
Journal:  Case Rep Dermatol Med       Date:  2015-09-08

Review 3.  Urticarial vasculitis.

Authors:  Stephanie L Gu; Joseph L Jorizzo
Journal:  Int J Womens Dermatol       Date:  2021-01-29

Review 4.  Vasculitides and the Complement System: a Comprehensive Review.

Authors:  Maria Sole Chimenti; Eleonora Ballanti; Paola Triggianese; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 10.817

5.  Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Authors:  Javier Loricera; Vanesa Calvo-Río; Cristina Mata; Francisco Ortiz-Sanjuán; Marcos A González-López; Lino Alvarez; M Carmen González-Vela; Susana Armesto; Héctor Fernández-Llaca; Javier Rueda-Gotor; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

Review 6.  Cutaneous and Mucosal Manifestations Associated with Celiac Disease.

Authors:  Luis Rodrigo; Valia Beteta-Gorriti; Nuria Alvarez; Celia Gómez de Castro; Alvaro de Dios; Laura Palacios; Jorge Santos-Juanes
Journal:  Nutrients       Date:  2018-06-21       Impact factor: 5.717

7.  Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.

Authors:  Ivan Cherrez-Ojeda; Emanuel Vanegas; Miguel Felix; Valeria L Mata; Annia Cherrez
Journal:  BMC Dermatol       Date:  2018-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.